Susceptibility of catheter-related Klebsiella pneumoniae strains to quaternary ammonium compounds under biofilm and planktonic conditions by Shakibaie, Mohammad Reaza et al.
Susceptibility of catheter-related Klebsiella pneumoniae 
strains to quaternary ammonium compounds under 
biofilm and planktonic conditions
Fatemeh Monirzadeh;1 Mohammad Reza Shakibaie;1,2,3 Melika Gholamrezazadeh;1 Shalaleh Masoumi1 
1 Department of Microbiology and Virology, Kerman University of Medical Sciences, Kerman, Iran
2 Research Center for Tropical Medicine and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran
3 Environmental Health Engineering Research Center, Kerman University of Medical Sciences, Kerman, Iran
Corresponding author: 
Mohammad Reza Shakibaie
Department of Microbiology and Virology
Kerman University of Medical Sciences
Kerman, Iran
Tel.: +98 3403221660
Fax: +98 3403221671
mr_shakibaei@kmu.ac.ir
ORIGINAL ARTICLE
Canadian Journal of Infection Control   |   Winter 2018   |   Volume 33   |   Issue 4   |   219-215
INTRODUCTION
Klebsiella pneumoniae is a gram-negative opportunistic 
pathogen, which is responsible for 10% of all hospital-acquired 
infections [1, 2]. This bacterium causes important diseases such 
as pneumonia, septicemia, urinary tract infections, wounds 
and intensive care unit infections in immunocompromised 
patients, diabetic patients, and still-born infants [3]. In recent 
years, the emergence of K. pneumoniae resistant to both 
antibiotics as well as biocides (disinfectants) has caused serious 
concern for infectious diseases specialists around the world 
[4]. It has been reported that about 60% to 70% of Klebsiella 
infections in hospitals are resistant to more than three classes 
of antibiotics [5]. Studies of pneumonia in Chinese hospitals 
revealed a pathogen unlike any the investigators had previously 
seen in healthcare settings. It was hyper-virulent K. pneumoniae 
harbouring various antibiotic resistance genes, a combination 
that causes severe, quick-developing, and deadly infections 
that are nearly impossible to treat with currently available drugs 
[6]. Both infections and antibiotic resistances in K. pneumoniae 
are often associated with the formation of biofilm. A biofilm is 
broadly considered a population of microorganisms grown on a 
surface or interface and embedded in a matrix of extracellular 
polymeric substances [7]. This will provide effective resistance 
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against large molecules such as antimicrobial agents, lysozyme, 
and biocides [8]. It has been estimated that biofilms can tolerate 
antimicrobial agents (disinfectants, antibiotics, surfactants) at 
concentrations of ten to 1,000 times that needed to inactivate 
genetically equivalent planktonic bacteria [8, 9]. The presence 
of catheters favours biofilm formation by providing an inert 
surface for the attachment of bacterial cells, thereby enhancing 
microbial colonization and the development of biofilm [10, 
11]. At present, there are few studies describing K. pneumoniae 
isolates resistant to benzalkonium chloride and Deconex 
through biofilm formation [12]. Reports suggest that, in the 
presence of benzalkonium chloride, biofilm development of K. 
pneumoniae was inhibited fourfold and the compound’s MIC 
value was reduced by one-eighth [13]. 
The primary aim of this study was to evaluate the 
susceptibility of K. pneumoniae to antibiotics, benzalkonium 
chloride, and Deconex under biofilm and planktonic conditions. 
Furthermore, we studied the prevalence of quaternary 
ammonium compound-resistant genes (qacEΔ1 and cepA) in 
these isolates.
METHODS
Bacterial samples and identification
A total of 85 non-duplicate strains of K. pneumoniae were 
isolated from catheter-associated specimens of 345 patients 
hospitalized in four referral hospitals in Kerman (southeastern 
Iran). Sampling was carried out from February to November 
2015. For each isolate, patient demographic data and culture site 
were obtained. The samples were collected from intravascular 
and urinary tract central catheters peripherally inserted by a 
trained laboratory technician that were inoculated into 5 ml 
Stuart transport medium (Merck Group, Darmstadt, Germany) 
and transferred to our lab within 24 hours of collection. The 
identification process was carried out based on biochemical and 
conventional diagnostic tests for Enterobacteriaceae, as described 
by Kilian and Bülow (1979) [14].
Compound sources and analysis
Biocides, benzalkonium chloride as standard concentrate 50% 
w/v solution, under trade name BC50, and Deconex were 
purchased from NIPCO chemical group (Tehran, Iran).
Determination of susceptibility to  
biocides under planktonic conditions
The MIC and minimum bactericidal concentration (MBC) of 
Deconex and benzalkonium chloride against isolates were 
determined with a broth microdilution test, explained in detail 
in a previous report [15]. In brief, 10 ml of 32 mg/ml stock 
solutions of benzalkonium chloride and Deconex were prepared 
and diluted to 0.015 mg/ml. 50 µl of each dilution was added to 
96-well microtiter plates containing 150 µl Luria-Bertani broth. 
To this preparation, 50 µl of the bacterial sample at 1 × 106 
colony-forming units (CFU)/ml was added. To prevent bacterial 
aggregations, the microtiter plates were incubated under shaking 
conditions (100 RPM) for 24 hours at 37° C. MIC was defined 
as the lowest concentration of the above compounds that 
inhibits bacterial growth (no visible growth). A loopful of MIC 
was then streaked into Muller-Hinton agar and checked for 
grown colonies after 24 hours’ incubation at 37° C. The number 
of colonies formed was considered the MBC. The MBC was 
defined as the lowest concentration of biocides killing at least 
99.9% of the initial inoculums. Simultaneously, E. coli ATTC 
25922 was used as a control strain. 
Biofilm formation under static conditions
Biofilm formation was quantified by the microtiter method, as 
described by O’Toole et al. (2000) [9]. In this method, 1:100 
diluted K. pneumoniae isolates at a concentration of  
1 × 106 CFU/ml were inoculated into a 96-well microtiter 
plate containing 100 µl of fresh Tryptic Soy Broth (TSB) 
(BioMérieux, Marcy-I’Étoile, France). Growths were monitored 
after 24 hours’ incubation at 37° C. Non-adherent cells were 
aseptically aspirated with pasture pipettes and washed with 
300 µL of phosphate-buffered saline (PBS) solution (pH 7.2) 
to remove any remaining suspended cells. The biofilm was 
subsequently stained with the addition of 150 µL of 0.2% 
safranin (Merck Group, Darmstadt, Germany) for 30 minutes. 
The stain was removed by thorough washing, once with PBS at 
a pH of 7.2 and then with distilled water. The wells containing 
biofilm matrix were kept at room temperature or at 60° C 
until dry. Quantification of cells in the biofilms was carried 
out by solubilization of dye with 300 µL of glacial acetic acid. 
Optical density at 480 nm was then measured for each well 
[15]. All mentioned experiments were performed in duplicate. 
Pseudomonas aeruginosa PAO1 was used as positive control for 
biofilm formation study.
MIC of antibiotics under planktonic and biofilm conditions 
Susceptibility of 12 strong biofilm-forming K. pneumoniae 
isolates to different antibiotics was determined under planktonic 
and biofilm conditions using the microdilution method [16]. 
In the case of planktonic conditions, the microtiter plates were 
incubated under shaking at 100 RPM for 18 hours. In case of 
biofilm, cells attached to the wall of the microtiter wells after 
24 hours were scraped in 1 ml of phosphate buffer (pH 7.2). 
The suspensions were then diluted to 1 × 106 CFU/ml using 5 
ml of D/W. 10 µl of bacterial suspensions was added to each 
microtiter well containing 100 µl of sterile TSB medium and 
50 µL different concentrations of antibiotics (0.5-516 µg/ml). 
The following antibiotics were used in this study: tigecycline, 
colistin, ceftazidime, imipenem, amikacin, cefotaxime, cefoxitin, 
gentamicin, ciprofloxacin, trimethoprim/sulfamethoxazole, 
piperacillin/tazobactam, tetracycline, and chloramphenicol 
(Mast Group Ltd., Bootle, Merseyside, UK). E. coli ATCC 25922 
was selected as a quality control strain in this antimicrobial 
susceptibility study.
Biofilm inhibitory activities of  
Deconex and benzalkonium chloride
The antibiofilm activities of Deconex and benzalkonium 
chloride were evaluated as described here. Briefly, microtiter 
plates containing 180 µl TSB medium were prepared. 10 
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µL of bacterial suspension at 10 × 106 CFU/ml and 10 µl 
Deconex and benzalkonium chloride preparation at a sub-
MIC concentration of 0.03 mg/ml were added to each well. 
The sub-MIC was defined as the highest concentration of the 
antimicrobial compounds that bacterial cells can grow and 
showing visible turbidity. The microtiter plates were kept at 37° 
C for 24 hours and the amount of biofilm formed in each well 
was measured as described above. Prior to the experiments, we 
measured the growth rate and viable count of each isolate in 
the absence and presence of biocides. The adherence efficiency 
was calculated as described by Stepanovi´c et al. (2007) [17]. 
Determination of biofilm eradication time
To determine biofilm eradication time, we decanted the 
contents of a microtiter plate with 24-hour biofilm treated 
with biocides for contact times of five, 15, 30, and 60 minutes. 
Microplate wells were then rinsed gently with sterile water 
and stained. The bound dye was re-solubilized in 33% glacial 
acetic acid. Absorbance was read as described by Leary et al. 
(2017) [18]. The combination of benzalkonium chloride at a 
concentration of 0.3 mg/ml and Deconex at a concentration of 
0.06 mg/ml was also used for biofilm eradication. 
Detection of qacEΔ1 and cepA genes by PCR
For PCR assays, the genomic DNA of each isolate was extracted 
using the boiling method and subjected to phenol/chloroform 
treatment. The cell lysate was centrifuged at 8.000 RPM for ten 
minutes and used to detect quaternary ammonium compounds 
(QACs) (qacEΔ1, cepA) genes with the PCR technique using a set 
of primer sequences F: 5-GCCCTACACAAATTGGGAGA-3 and 
R: 5-CTGCGGTACCACTGCCACAA-3 specific for the qacEΔ1 
gene; and primer pairs F: 5-CAACTCCTTCGCCTATCCCG-3 
and R: 5-TCAGGTCAGACCAAACGGCG-3 specific for the cepA 
gene [19]. The PCR assay was carried out using a temperature 
gradient thermal cycler (Biometra-T300, Göottingen, Germany). 
The amplification program consisted of an initial denaturation 
at 95° C for 300 seconds, 95° C for 30 cycles for 30 seconds, 
annealing 60° C for 35 seconds, extension at 72° C for 40 
seconds, and final extension at 72° C for 300 seconds. The 100 
bp DNA Ladder was used as a molecular weight standard. 
Statistical analysis
The SPSS program version 17.0 for Windows (SPSS, Chicago, 
IL, U.S.A.) was used for statistical analysis. Data are presented 
as the mean ± standard error of the mean. For all tests, a two-
sided p-value < 0.05 was considered significant. 
RESULTS 
Biofilm quantification revealed that 15% of the isolates showed 
strong biofilm activity, 40% showed moderate activity, 30% 
showed weak activity, and 15% showed no biofilm activity. 
However, no significant antibiofilm activity of benzalkonium 
chloride and Deconex were detected after exposure of the 
isolates to a sub-MIC concentration of 0.05 mg/ml (p ≤ 0.05), 
as shown in Figure 1. Further analysis of the susceptibility of 
K. pneumoniae to antibiotics grown under planktonic and 
FIGURE 1: Biofilm formation and the effect of benzalkonium chloride and Deconex on biofilm in K. pneumoniae  
multidrug-resistant isolates. No statistical significance in the amount of biofilm masses was observed in the presence  
and absence of these agents.
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biofilm conditions (Figure 2) revealed a significant increase 
in the MIC level for the piperacillin/tazobactam, tetracycline, 
chloramphenicol, trimethoprim/sulfamethoxazole, and 
cefotaxime antibiotics for cells taken from 24 hour biofilm. 
Resistance to imipenem and ceftazidime increased more than 
fourfold; however, in the case of tigecycline and colistin, the 
MIC did not differ under planktonic and biofilm growths (Figure 
2). These differences were statistically significant, with a p-value 
of < 0.05. To assess the antimicrobial activity of benzalkonium 
chloride and Deconex, we performed MIC and MBC tests 
using different concentrations of the above biocides. More than 
58.8% and 35.2% of the isolates exhibited an MIC of 0.015 mg/
ml to benzalkonium chloride and Deconex under planktonic 
conditions, while 17.6% and 18.8% of the isolates showed an 
MIC of 0.03 mg/ml to the above compounds. We detected 
one isolate with an MBC of 1 mg/ml to benzalkonium chloride 
(isolate 53) and one isolate with an MIC of 4 mg/ml to Deconex 
(isolate 43), respectively.
The results of survival curves of the planktonic cells 
and biofilm eradication time in the presence of biocides 
are illustrated in Figures 3a and 3b. Here, benzalkonium 
chloride at a concentration of 0.03 mg/ml and Deconex at 
a concentration of 0.06 mg/ml reduced bacterial population 
to 3 log 10 units within four hours of exposure (Figure 3a). 
Further exposure of planktonic cells to biocides indicated a 
continuous drop of viable cells with no detectable CFUs after 
eight hours of incubation. Furthermore, we challenged biofilms 
with benzalkonium chloride at concentrations of 0.03 mg/ml 
and Deconex at concentrations of 0.06 mg/ml, respectively. 
A minimum biofilm eradication time assay revealed that 
both biocides were not effective against preformed biofilm 
at the recommended time of five minutes, but that they 
eradicated the biofilm masses from microplate wells after 30 
minutes’ exposure (Figure 3b). In addition, combinations of 
benzalkonium chloride at a concentration of 0.03 mg/ml and 
Deconex at a concentration of 0.06 mg/ml had a synergistic 
effect and removed most of the biofilm from the microtiter 
wells within five minutes of incubation (Figure 3b). PCR 
analysis showed the presence of cepA in 15% of the isolates 
showing strong biofilm, while the qacEΔ1 gene was absent in 
this study. 
DISCUSSION
The U.S. Centers for Disease Control and Prevention alone 
records nearly 560,000 catheter-related urinary tract infections 
in U.S. hospitals [20]. Catheterization increases the risk of 
developing bacteriuria by about 3% to 6% per day. Almost 
50% of short-term catheterized patients acquire infections 
within this period, whereas the risk of infection from long-term 
catheters is 100% [21].
In the present study, we selectively isolated K. pneumoniae 
strains from catheters in four hospitals and exposed them 
FIGURE 2: Antibiotic susceptibility of K. pneumoniae under biofilm and planktonic conditions. MIC was defined as the  
lowest concentration of antibiotics that inhibits growth (visible turbidity) after 24 hours of incubation. 
Legend
Abbreviations: 
CAZ: ceftazidime
CTX:  cefotaxime
PZT: piperacillin/ 
tazobactam
CIP:  ciprofloxacin
IMP:  imipenem
TIG: tigecycline
CLS:  colistin
TE:  tetracycline
C:  chloramphenicol
Gm:  gentamicin
SXT:  sulfamethoxazole/ 
trimethoprim
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FIGURE 3a: Survival of K. pneumoniae in the presence of benzalkonium chloride and Deconex. The above results are the 
average of two replicate experiments.
FIGURE 3b: Eradication of biofilm in the presence of benzalkonium chloride and Deconex at different time intervals.  
Mean values and standard deviation of the compounds are indicated by the error bar.
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to different concentrations of Deconex and benzalkonium 
chloride. Both compounds act on the cell membrane, causing 
the dissociation of the bilayer membrane and the disruption of 
cell permeability. Our results show a high rate of sensitivity to 
these compounds by strains of K. pneumoniae (average MIC to 
Deconex of 0.06 ± 0.2 mg/ml and benzalkonium chloride of 
0.03 ± 0.01 mg/ml). However, the compounds did not exert 
biofilm inhibitory activity. A recent study revealed that bacterial 
adherence to the benzalkonium chloride-impregnated 
catheters was significantly reduced compared with control 
catheters containing no antimicrobial agent (p < 0.01) [22]. 
Furthermore, we found a direct relationship between biofilm 
formation and high MIC values to antibiotics, which highlights 
how current planktonic-based antimicrobial susceptibility tests 
are often misleading [23]. This increased resistance occurs 
mainly in mature biofilms and is attributed to the formation 
of antibiotic-tolerant subpopulations in the deeper layers of 
biofilms in combination with impaired molecule diffusion 
[24]. A fourfold increase in MIC to imipenem in biofilm-grown 
cells was unexpected; Chen et al. (2014) [25] reported that 
imipenem displayed potent activity against established K. 
pneumoniae biofilms under both static and flow conditions 
in vitro, while Vuotto et al. (2017) [26] demonstrated that the 
association of biofilm production and imipenem resistance in 
K. pneumoniae was statistically significant. Recently, research 
has been directed at understanding why antibiotics do not 
effectively penetrate biofilms (specific antibiotics are required 
at higher dosages to treat biofilms) [27]. 
There was no significant relationship between antibiotic 
resistance and resistance to biocides in our study. On the 
contrary, many isolates were susceptible to biocides but 
resistant to antibiotics. We propose that hand hygiene, contact 
precautions, active patient screening, and disinfecting hospital 
equipment and catheter-related devices with these compounds 
at concentrations of 0.03 mg/ml can effectively reduce the 
transmission of infections caused by K. pneumoniae planktonic 
cells but not biofilm conditions. A population-based study on 
bloodstream infections caused by K. pneumoniae from 2000 to 
2007 in Canada, a setting with low prevalence of antimicrobial 
resistance, showed an increase of the burden of disease during 
the last decade and a case fatality rate of 19% [28]. 
Our data also suggest that for resistance to QACs, the 
presence of both qacEΔ1 and cepA genes is essential. The 
absence of the qacEΔ1 gene led to sensitivity to these biocides. 
One study performed in Tehran hospitals investigated the 
susceptibility of 26 isolates of K. pneumoniae to a hospital 
biocide in the presence of qacEΔ1 and cepA genes [19]. 
The qacEΔ1 and cepA genes were detected in 26 and 19 
biocide-resistant isolates. The results suggest that susceptibility 
to biocide in clinical isolates of K. pneumoniae is directly 
related to the presence of both qacEΔ1 and cepA genes. 
Similarly, it has been shown that 50%, 49%, and 53% of K. 
pneumoniae strains had reduced susceptibility to chlorhexidine 
and benzalkonium chloride. The antiseptic-resistant genes 
cepA and qacEΔ1 were found in 56, 34, and one isolates, 
respectively [19].
CONCLUSION
Based on the above data, we concluded that benzalkonium 
chloride and Deconex antiseptics are very good at controlling 
infections caused by K. pneumoniae planktonic cells and could 
be included in the antimicrobial stewardship program of our 
hospitals. 
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